Invesco Ltd. Kura Oncology, Inc. Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 182,687 shares of KURA stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

182,687

Previous 140,731 29.81%

Holding current value

$2.05 Million

Previous $812,000 99.01%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$5.54 - $9.05 $232,436 - $379,701	41,956 Added 29.81%	182,687 $1.62 Million
Q2 2025 Aug 13, 2025	BUY	$5.55 - $6.92 $241,508 - $301,123	43,515 Added 44.76%	140,731 $812,000
Q1 2025 May 12, 2025	BUY	$6.6 - $9.05 $197,854 - $271,300	29,978 Added 44.58%	97,216 $641,000
Q4 2024 Feb 13, 2025	BUY	$8.51 - $19.21 $6,799 - $15,348	799 Added 1.2%	67,238 $585,000
Q3 2024 Nov 12, 2024	SELL	$18.57 - $23.23 $3.02 Million - $3.78 Million	-162,760 Reduced 71.01%	66,439 $1.3 Million

Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $1.49 Million - $1.95 Million	-84,873 Reduced 27.02%	229,199 $4.72 Million
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $3.29 Million - $5.76 Million	244,945 Added 354.34%	314,072 $6.7 Million
Q4 2023 Feb 12, 2024	BUY	$7.58 - $14.38 $77,558 - $147,136	10,232 Added 17.37%	69,127 $994,000
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $7,688 - $10,804	911 Added 1.57%	58,895 $537,000
Q2 2023 Aug 11, 2023	SELL	$9.62 - $13.99 $20,365 - $29,616	-2,117 Reduced 3.52%	57,984 $613,000
Q1 2023 May 12, 2023	SELL	$10.71 - $14.6 $98,221 - $133,896	-9,171 Reduced 13.24%	60,101 $735,000
Q4 2022 Feb 13, 2023	SELL	$11.23 - $16.9 $437 - $659	-39 Reduced 0.06%	69,272 $859,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $31,153 - $50,453	-2,594 Reduced 3.61%	69,311 $947,000
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $99,688 - $170,615	9,308 Added 14.87%	71,905 $1.32 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $20.5 Million - $29.5 Million	-1,738,030 Reduced 96.52%	62,597 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $14.7 Million - $23.5 Million	-1,199,513 Reduced 39.98%	1,800,627 $25.2 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $22.7 Million - $32 Million	1,475,350 Added 96.76%	3,000,140 $56.2 Million
Q2 2021 Aug 17, 2021	SELL	$20.85 - $29.88 $3.55 Million - $5.09 Million	-170,422 Reduced 10.05%	1,524,790 $31.8 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $35 Million - $55.3 Million	1,412,295 Added 499.19%	1,695,212 $47.9 Million
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $831,923 - $1.19 Million	-28,687 Reduced 9.21%	282,917 $9.24 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $5.08 Million - $9.55 Million	311,604 New	311,604 $9.55 Million

Others Institutions Holding KURA

# of Institutions

213

Shares Held

81.2M

Call Options Held

900K

Put Options Held

228K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account